Lytic peptide biosensor and methods of making and using the same
AssigneeDeetex, LLC
InventorsJames Hartmann, Ryan Landis, Michelle Ryan, Yousseff Mottii
Life of this patent
Estimating the term…
Loading patent…
AssigneeDeetex, LLC
InventorsJames Hartmann, Ryan Landis, Michelle Ryan, Yousseff Mottii
Estimating the term…
The presently disclosed subject matter is directed to an assay that detects and quantitatively determines the activity of a lytic peptide that exhibits antimicrobial activity, such as LL-37. Particularly, the assay comprises inducing and/or transfecting bacteria to produce high levels of an enzyme, such as β-galactosidase. The bacteria are then preserved by lyophilization. After a desired amount of time, the bacteria are hydrated with a target sample from a subject suspected of having a specific disease or disorder characterized by an increase in levels of lytic peptide. In the presence of lytic peptide, the enzyme is released from the interior of the bacteria, which can then be detected by alteration of the enzyme substrate. In the absence of lytic peptide, the enzyme remains within the bacteria and no detection of the enzyme occurs.
An in vitro method for detecting the presence and activity of a membrane lytic peptide in a sample, the method comprising:
A method of detecting a chronic condition or disorder in a subject, wherein the chronic condition or disorder is characterized by the presence of an antimicrobial membrane lytic peptide, the method comprising:
Dependencies are inferred from the claim text.